A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect

Table 5

Survival rate of mice received i.v. injections of Taxol or paclitaxel liposomes at doses of 20 and 40 mg/kg.

	Dose (mg/kg)	Survival Rate
Taxol	20	4/5
	40	1/5
Liposomal paclitaxel	40	8/8